Clinical-stage biotech Alterity Therapeutics has appointed internationally recognised neurologist Dr Daniel O Claassen as Chief Medical Advisor as it advances its lead drug candidate ATH434 toward a ...

MELBOURNE, Australia and INDIANAPOLIS, March 10, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces ...

Analyst sentiment across three small-cap biotechs has turned notably positive, with fresh coverage initiations and maintained ...

As previously presented, gedatolisib + palbociclib + fulvestrant ('gedatolisib triplet”) and gedatolisib + fulvestrant ('gedatolisib doublet”) reduced the risk of disease progression or death versus ...

Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.

Fourteen-year collaboration enters a new phase as Menarini evolves its use of the Medidata Platform, combining established ...

Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...

Early prediction and identification of neurodegenerative diseases offers the best chance for prevention and treatment.

Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) announced on March 6, 2026 that ...

The Minns Labor Government is providing a funding boost to an Australian-first alliance that's fast-tracking cancer patients across NSW onto ...

The Minns Labor Government is providing a funding boost to an Australian-first alliance that's fast-tracking cancer patients across NSW onto ...